Table 1.
Sociodemographic and Clinical Variables | n | % |
---|---|---|
Sex | ||
Males | 404 | 36.5 |
Females | 704 | 63.5 |
Age group | ||
18–39 years | 220 | 19.9 |
40–49 years | 183 | 16.5 |
50–59 years | 327 | 29.5 |
60–69 years | 233 | 21.0 |
≥70 years | 145 | 13.1 |
Education a | ||
Elementary school (8–9 years) | 248 | 22.4 |
Junior high school (10 years) | 367 | 33.2 |
High school/university (≥11 years) | 486 | 44.0 |
No formal qualification | 4 | 0.4 |
Employment status a | ||
Employed | 703 | 63.7 |
Unemployed | 43 | 3.9 |
Retired | 282 | 25.5 |
Other | 76 | 6.9 |
Tumor localization | ||
Breast | 381 | 34.4 |
Gastrointestinal tract | 171 | 15.4 |
Prostate | 144 | 13.0 |
Hematological | 131 | 11.8 |
Female genital organs | 78 | 7.0 |
Thyroid/endocrine glands | 36 | 3.2 |
Melanoma | 26 | 2.3 |
Male genital organs | 23 | 2.1 |
Others | 118 | 10.6 |
Time since diagnosis a | ||
<6 month | 334 | 30.2 |
6 month– < 12 months | 374 | 33.8 |
≥12 months | 399 | 36.0 |
Treatment | ||
Surgery a | ||
No | 121 | 10.9 |
Yes | 986 | 89.1 |
Chemotherapy a | ||
No | 508 | 46.1 |
Yes | 595 | 53.9 |
Radiotherapy a | ||
No | 538 | 50.2 |
Yes | 534 | 49.8 |
Hormone therapy a | ||
No | 780 | 74.0 |
Yes | 274 | 26.0 |
Antibody therapy a | ||
No | 864 | 82.8 |
Yes | 179 | 17.2 |
a Missing data not reported.